CheckMan Stock Market Overview

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In The Chemours To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in The Chemours between February 20, 2026 and August 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - October 28, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against The Chemours Company ("The Chemours" or the "Company") (NYSE: CC) and reminds investors of the December 7, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

A securities class action names Unicycive Therapeutics' Chief Executive Officer and Chief Financial Officer as individual defendants under Section 20(a) control person claims, alleging they controlled disclosures telling shareholders a third-party manufacturer had made "significant progress" toward FDA compliance that the Company had never verified through its own inspection. NEW YORK, Oct. 28, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. (NASDAQ: UNCY) that a securities class action naming Chief Executive Officer Shalabh Gupta and Chief Financial Officer John Townsend as individual defendants has been filed on behalf of shareholders who purchased securities between December 29, 2025 and June 29, 2026.

Promise vs. Reality: The Qfin Performance Gap.

Oracle shares ORCL rose more than 11% on Wednesday after the company reaffirmed its fiscal 2027 outlook and issued long-term financial targets, offering investors greater clarity on the expected returns from its artificial intelligence infrastructure spending. At its financial analyst day in Las Vegas, the cloud and database company said it expects revenue of at least $90 billion and adjusted earnings of $8.10 per share for fiscal 2027.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Qfin To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Qfin between March 18, 2026 and August 25, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - October 28, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Qfin Holdings, Inc. ("Qfin" or the "Company") (NASDAQ: QFIN) and reminds investors of the November 30, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

S&P Global explores separating Capital IQ businesses, raises its 2026 earnings outlook and highlights strong Indices growth and accelerating AI adoption.

Applied Optoelectronics CATV business gains traction on DOCSIS 4.0 upgrades, strong amplifier shipments, and expanding customer adoption, boosting its growth prospects against rivals.

We assess the investment worthiness of ALK stock post its third-quarter 2026 earnings release.

Société BIC SA (BICEY) Q3 2026 Sales/Trading Call Transcript

Highwoods Properties, Inc. ( HIW ) Q3 2026 Earnings Call October 28, 2026 11:00 AM EDT Company Participants Brendan Maiorana - Executive VP & CFO Theodore Klinck - President, CEO & Director Brian Leary - Executive VP & COO Conference Call Participants Seth Bergey - Citigroup Inc., Research Division Blaine Heck - Wells Fargo Securities, LLC, Research Division Robert Stevenson - Huntington Securities, Inc., Research Division Nicholas Thillman - Robert W. Baird & Co. Incorporated, Research Division Peter Abramowitz - Deutsche Bank AG, Research Division William Catherwood - BTIG, LLC, Research Division Dylan Burzinski - Green Street Advisors, LLC, Research Division Ronald Kamdem - Morgan Stanley, Research Division Presentation Operator Hello, everyone.